Refractory Henoch-Schönlein Purpura: Atypical Aetiology And Management

Journal of Renal Care

Volumn 39, Issue 2, 2013, Pages 77-81

  El Husseini, Amr ^a   Ahmed, Ahmed ^a   Sabucedo, Alberto ^b   Fabulo, Edward ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Suncoast Medical Clinic   (United States)

Author keywords

Glomeruloneprhitis; Henoch Sch nlein purpura; Lisinopril; Rituximab; Vasculitis

Indexed keywords

IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; BIOPSY; CASE REPORT; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; NEPHRITIS; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BIOPSY; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOLOGIC FACTORS; MALE; NEPHRITIS; PURPURA, SCHOENLEIN-HENOCH; TREATMENT OUTCOME;

EID: 84878040726     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2013.12007.x     Document Type: Article

References (24)

1. Aktas B., Topcuoglu P., Kurt O.K. et al. (2009). Severe Henoch-Schönlein purpura induced by cytarabine. Annals of Pharmacotherapy 43(4), 792-793.
2. Bergstein J. et al. (1998). Response of crescentic Henoch-Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clinical Nephrology 49, 9-14.
3. Blier P. (2003). Brand versus generic medications: the money, the patient and the research. Journal of Psychiatry and Neuroscience 28(3), 167-168.
4. Borrás-Blasco J. et al. (2003). Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature. International Journal of Clinical Pharmacology and Therapeutics 41(5), 213-216.
5. Chartapisak W. et al. (2009). Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura. The Cochrane Database of Systematic Reviews 8(3), CD005128.
6. Choi S.J. et al. (2002). A case of refractory Henoch-Schönlein purpura treated with thalidomide. Korean Journal of Internal Medicine 17, 270-273.
7. Coppo R. et al. (2006). Predictors of outcome in Henoch-Schönlein purpura in children and adults. American Journal of Kidney Diseases 47, 993-1003.
8. Dede F. et al. (2008). Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions. Scandinavian Journal of Urology and Nephrology 42, 178-180.
9. Disdier P. et al. (1992). Adult Schönlein-Henoch purpura after lisinopril. Lancet 340(8825), 985.
10. Donnithorne K.J. et al. (2009). Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. Journal of Pediatrics 155(1), 136-139.
11. Fervenza F. et al. (in press). Rituximab in progressive IgA nephropathy. NCT 0049 8368. http://clinicaltrials.gov/ct2/show/NCT00498368.
12. Gedalia A. (2004). Henoch-Schonlein purpura. Current Rheumatology Reports 6, 195-202.
13. Hattori M. et al. (1999). Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. American Journal of Kidney Diseases 33, 427-433.
14. Kesselfreim A.S. et al. (2008). Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA 300(21), 2514-2526.
15. Kusuda A. et al. (1999). Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins. Intern Med 38(4), 376-379.
16. Moots J. et al. (1992). Adult Henoch-Schönlein Purpura after enalapril. LANCET 1 340(8814), 304-305.
17. Ninchoji T. et al. (2011). Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity. Pediatric Nephrology 26(4), 563-569.
18. Pillebout E. et al. (2002). Henoch-Schonlein purpura in adults: outcome and prognostic factors. Journal of the American Society of Nephrology 13, 1271-1278.
19. Pillebout E. et al. (2011). Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report. Nephrology, Dialysis, Transplantation 26(6), 2044-2046.
20. Rauta V. et al. (2002). Henoch-Schönlein nephritis in adults-clinical features and outcomes in Finnish patients. Clinical Nephrology 58, 1-8.
21. Saulsbury F.T. (1999). Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78, 395-409.
22. Shrestha S. et al. (2006). Henoch-Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. Quarterly Journal of Medicine 99, 253-265.
23. Strom B.L. (1987). Generic drug substitution revisited. New England Journal of Medicine 316(23), 1456-1462.
24. Sugiyama H. et al. (2005). Successful treatment of progressive Henoch-Schönlein purpura nephritis with tonsillectomy and steroid pulse therapy. Internal Medicine 44, 611-615.